期刊文献+

血清补体C1q水平对冠心病诊断价值的Meta分析

Diagnostic value of serum complement C1q level in coronary heart disease:a Meta-analysis
下载PDF
导出
摘要 [目的]分析血清补体C1q水平对冠心病的诊断价值。[方法]计算机检索中国知网、万方数据库、PubMed、Web of Science、Cochrane、Embase等数据库,搜集血清补体C1q水平对冠心病诊断价值的病例-对照研究,检索时间截至2021年9月。采用RevMan5.4和Stata16.0软件进行Meta分析。[结果]共有10篇文献符合纳入标准,研究对象共计2 011例,Meta分析结果显示血清补体C1q水平在冠心病组与对照组中的差异无统计学意义(SMD=-0.19,95%CI:-0.85~0.48,P=0.58)。[结论]血清补体C1q水平也许不能够作为冠心病诊断的一项指标。 Aim To evaluate the diagnostic value of serum complement C1 q level in coronary heart disease. Methods Case-control studies on the diagnostic value of serum complement C1 q level in coronary heart disease were collected by computer retrieval from CNKI, Wanfang, PubMed, Web of Science, Cochrane, Embase and other databases until September 2021. Meta-analysis was performed using RevMan 5.4 and Stata16.0 software. Results A total of 10 literatures met the inclusion criteria, involving a total of 2 011 subjects. Meta-analysis showed that there was no significant difference in serum complement C1 q level between the coronary heart disease group and the control group(SMD=-0.19, 95%CI:-0.85~0.48,P=0.58). Conclusion Serum complement C1 q level may not be a diagnostic indicator of coronary heart disease.
作者 胡康 张开健 施展 张步春 HU Kang;ZHANG Kaijian;SHI Zhan;ZHANG Buchun(Graduate School of Wannan Medical College,Wuhu,Anhui 241000,China;Department of Cardiology,Anhui Provincial Hospital Affiliated to Anhui Medical University,Hefei,Anhui 230001,China;The First Affiliated Hospital of University of Science and Technology of China,Hefei,Anhui 230001,China)
出处 《中国动脉硬化杂志》 CAS 2022年第11期982-986,共5页 Chinese Journal of Arteriosclerosis
基金 安徽省卫生健康委科研资助项目(AHWJ2021b082)。
关键词 冠心病 血清补体C1q META分析 coronary heart disease serum complement C1q Meta-analysis
  • 相关文献

参考文献14

二级参考文献83

  • 1陈羽斐,沈伟,施海明.巨噬细胞免疫代谢与动脉粥样硬化的研究进展[J].中国动脉硬化杂志,2020,0(1):74-80. 被引量:24
  • 2Lappegard KT, Garred P,Jonasson L, et al. A vital role for complement in heart disease [J]. Mol Immunol, 2014, 61(2);126-134. 被引量:1
  • 3Hertle E, Stehouwer CD, van Greevenbroek MM. The complement system in human cardiometabolic disease [J]. Mol Immunol,2014, 61(2):135-148. 被引量:1
  • 4Asgari E, Le Friec G, Yamamoto Hf et al. G3a modulates IL- 1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation[J]. Blood,2013 ,122(20):3473-3481. 被引量:1
  • 5O'Barr S, Cooper NR. The C5a complement activation peptide increases IL-1beta and IL-6 release from amyloid-beta primed human monocytes : Implications for Alzheimer's disease [J]. J Neuroimmunol,2000 ,109(2):87-94. 被引量:1
  • 6Wezel A, de Vries MR, Lagraauw HM, et al. Complement factor C5a induces atherosclerotic plaque disruptions [J]. J Cell Mol Med,2014,18(10):2020-2030. 被引量:1
  • 7Fraser DA,Tenner AJ. Innate immune proteins Clq and mannan- binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages [J]. J Immunol,2010,185(7):3932-3939. 被引量:1
  • 8Bohlson SS, O, Conner SD, Hulsebus HJ, et al. Complement, clq, and clq-related molecules regulate macrophage polarization [J]. Front Immunol,2014 ,21(5):402. 被引量:1
  • 9Spivia W,Magno PS, Le P, et al. Complement protein Clq promotes macrophage anti -inflammatory M2-like polarization during the clearance of atherogenic lipoproteins[J]. Inflamm Res,2014,63(10):885-893. 被引量:1
  • 10Bhatia VK, Yun S, Leung V, et al. Complement Clq reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice[J]. Am J Pathol,2007 ,170(1):416-426. 被引量:1

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部